FDA
approval
· 2021-04-06
FDA Approved: BUDESONIDE INHALATION SUSPENSION — Supplemental Application (Cipla USA Inc.)
Summary
The FDA approved a supplemental application for budesonide inhalation suspension from Cipla USA Inc. This approval adds or modifies the product labeling/indicat…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUDESONIDE INHALATION SUSPENSION (BUDESONIDE)